Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosenta Inc. C.ZRO

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It also develops chemical compounds designed to eliminate harmful microorganisms, such as bacteria, fungi, and viruses for household and industrial uses, while ensuring safety for both humans and the... see more

CSE:ZRO - Post Discussion

Biosenta Inc. > Biosenta and Am Gill featured on Stockhouse’s Power Play
View:
Post by Bandit22 on Aug 10, 2023 2:09pm

Biosenta and Am Gill featured on Stockhouse’s Power Play

Biosenta's tri-filler technology was featured on Stockhouse today. I have attached a link I think will work. 


https://thepowerplay.jwpapp.com/m/z75fsDPr/biosenta-inc-with-ceo-am-gill-august-10-2023?list=CQw6yjwj

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities